Conferences 2016

Oral presentations

J. Rak, L. Chomicz-Mańka, S. Makurat, K. Westphal, J. Wiczk, P. Wityk, M. Zdrowowicz, M. Wieczór, J. Czub
Hydrated electrons and Trojan horse radiotherapy. Computational and experimental studies
Modeling and Design of Molecular Materials 2016, Trzebnica, 26-30.06.2016

K. Butowska, M. Zdrowowicz, M. Sosnowska P. Spisz, I. Serdiuk, J. Rak
Ocena cytotoksyczności pochodnych uracylu jako potencjalnych sensybilizatorów DNA
XLV Ogólnopolska Szkoła Chemii “Chemia na fali”, Rozewie, 10-14.11.2016

Poster presentations

K. Westphal, J. Rak
Photodamage to the labelled DNA with 5-bromo-2’- deoxyuridine and its dependency on local DNA sequence
13th International Conference on Fundamental and Applied Aspects of Physical Chemistry, Belgrade, Serbia, 26-30.09.2016

P. Spisz, M. Zdrowowicz, J. Rak
Synthesis of 5-thiocyanato-2’-deoxyuridine 5’-triphosphate
13th International Conference on Fundamental and Applied Aspects of Physical Chemistry, Belgrade, Serbia, 26-30.09.2016

M. Sosnowska
Multi-step synthesis of 5’-protected 5-cyanato-2’- deoxyuridine
13th International Conference on Fundamental and Applied Aspects of Physical Chemistry, Belgrade, Serbia, 26-30.09.2016

S. Makurat, L. Chomicz-Mańka
Damages caused by the presence of 5-uracilyl radical in short, double-stranded DNA: ONIOM calculations
13th International Conference on Fundamental and Applied Aspects of Physical Chemistry, Belgrade, Serbia, 26-30.09.2016

P. Wityk, J. Rak
Radiosensitizing properties of labelled DNA-peptide conjugates
13th International Conference on Fundamental and Applied Aspects of Physical Chemistry, Belgrad, Serbia, 26-30.09.2016

S. Makurat, L. Chomicz-Mańka, P. Wityk, J. Rak
Adenine radical induced DNA lesions
14th International Workshop on Radiation Damage to DNA, Melbourne, Australia, 20-24.03.2016

P. Wityk, J. Rak
Model systems for studying DNA sensitization
14th International Workshop on Radiation Damage to DNA, Melbourne, Australia, 20-24.03.2016

M. Sosnowska, L. Chomicz-Mańka, J. Rak
Synthesis of 5-cyanatouracil derivative: A prospective DNA damage sensitizer
Cancer Biotherapeutics, London, UK, 14-16.03.2016